Articles producció científica> Bioquímica i Biotecnologia

Postdiagnosis body fatness, weight change and breast cancer prognosis: Global Cancer Update Program (CUP global) systematic literature review and meta-analysis

  • Dades identificatives

    Identificador: imarina:9286863
    Autors:
    Chan, Doris S. M.Vieira, RitaAbar, LeilaAune, DagfinnBalducci, KatiaCariolou, MargaritaGreenwood, Darren C.Markozannes, GeorgiosNanu, NeeshaBecerra-Tomas, NereaGiovannucci, Edward L.Gunter, Marc J.Jackson, Alan A.Kampman, EllenLund, VivienAllen, KateBrockton, Nigel T.Croker, HelenKatsikioti, DaphneMcGinley-Gieser, DeirdreMitrou, PanagiotaWiseman, MartinCross, Amanda J.Riboli, ElioClinton, Steven K.McTiernan, AnneNorat, TeresaTsilidis, Konstantinos K.
    Resum:
    Previous evidence on postdiagnosis body fatness and mortality after breast cancer was graded as limited-suggestive. To evaluate the evidence on body mass index (BMI), waist circumference, waist-hip-ratio and weight change in relation to breast cancer prognosis, an updated systematic review was conducted. PubMed and Embase were searched for relevant studies published up to 31 October, 2021. Random-effects meta-analyses were conducted to estimate summary relative risks (RRs). The evidence was judged by an independent Expert Panel using pre-defined grading criteria. One randomized controlled trial and 225 observational studies were reviewed (220 publications). There was strong evidence (likelihood of causality: probable) that higher postdiagnosis BMI was associated with increased all-cause mortality (64 studies, 32 507 deaths), breast cancer-specific mortality (39 studies, 14 106 deaths) and second primary breast cancer (11 studies, 5248 events). The respective summary RRs and 95% confidence intervals per 5 kg/m(2) BMI were 1.07 (1.05-1.10), 1.10 (1.06-1.14) and 1.14 (1.04-1.26), with high between-study heterogeneity (I-2 = 56%, 60%, 66%), but generally consistent positive associations. Positive associations were also observed for waist circumference, waist-hip-ratio and all-cause and breast cancer-specific mortality. There was limited-suggestive evidence that postdiagnosis BMI was associated with higher risk of recurrence, nonbreast cancer deaths and cardiovascular deaths. The evidence for postdiagnosis (unexplained) weight or BMI change and all outcomes was graded as limited-no conclusion. The RCT showed potential beneficial effect of intentional weight loss on disease-free-survival, but more intervention trials and well-designed observational studies in diverse populati
  • Altres:

    Autor segons l'article: Chan, Doris S. M.; Vieira, Rita; Abar, Leila; Aune, Dagfinn; Balducci, Katia; Cariolou, Margarita; Greenwood, Darren C.; Markozannes, Georgios; Nanu, Neesha; Becerra-Tomas, Nerea; Giovannucci, Edward L.; Gunter, Marc J.; Jackson, Alan A.; Kampman, Ellen; Lund, Vivien; Allen, Kate; Brockton, Nigel T.; Croker, Helen; Katsikioti, Daphne; McGinley-Gieser, Deirdre; Mitrou, Panagiota; Wiseman, Martin; Cross, Amanda J.; Riboli, Elio; Clinton, Steven K.; McTiernan, Anne; Norat, Teresa; Tsilidis, Konstantinos K.;
    Departament: Bioquímica i Biotecnologia
    Autor/s de la URV: Becerra Tomás, Nerea
    Paraules clau: Weight change To-hip ratio Systematic review Risk-factors Receiving adjuvant chemotherapy Pathological complete response Neoadjuvant chemotherapy Mass index bmi Life-style factors Evidence grading Endocrine therapy Early-stage Disease-free survival Breast cancer survival Body fatness
    Resum: Previous evidence on postdiagnosis body fatness and mortality after breast cancer was graded as limited-suggestive. To evaluate the evidence on body mass index (BMI), waist circumference, waist-hip-ratio and weight change in relation to breast cancer prognosis, an updated systematic review was conducted. PubMed and Embase were searched for relevant studies published up to 31 October, 2021. Random-effects meta-analyses were conducted to estimate summary relative risks (RRs). The evidence was judged by an independent Expert Panel using pre-defined grading criteria. One randomized controlled trial and 225 observational studies were reviewed (220 publications). There was strong evidence (likelihood of causality: probable) that higher postdiagnosis BMI was associated with increased all-cause mortality (64 studies, 32 507 deaths), breast cancer-specific mortality (39 studies, 14 106 deaths) and second primary breast cancer (11 studies, 5248 events). The respective summary RRs and 95% confidence intervals per 5 kg/m(2) BMI were 1.07 (1.05-1.10), 1.10 (1.06-1.14) and 1.14 (1.04-1.26), with high between-study heterogeneity (I-2 = 56%, 60%, 66%), but generally consistent positive associations. Positive associations were also observed for waist circumference, waist-hip-ratio and all-cause and breast cancer-specific mortality. There was limited-suggestive evidence that postdiagnosis BMI was associated with higher risk of recurrence, nonbreast cancer deaths and cardiovascular deaths. The evidence for postdiagnosis (unexplained) weight or BMI change and all outcomes was graded as limited-no conclusion. The RCT showed potential beneficial effect of intentional weight loss on disease-free-survival, but more intervention trials and well-designed observational studies in diverse populations are needed to elucidate the impact of body composition and their changes on breast cancer outcomes.
    Àrees temàtiques: Saúde coletiva Química Oncology Odontología Nutrição Medicina veterinaria Medicina iii Medicina ii Medicina i Interdisciplinar General medicine Educação física Ciências biológicas iii Ciências biológicas ii Ciências biológicas i Ciência de alimentos Cancer research Biotecnología Biodiversidade
    Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
    Adreça de correu electrònic de l'autor: nerea.becerra@urv.cat
    Identificador de l'autor: 0000-0002-4429-6507
    Data d'alta del registre: 2024-08-03
    Versió de l'article dipositat: info:eu-repo/semantics/publishedVersion
    Enllaç font original: https://onlinelibrary.wiley.com/doi/10.1002/ijc.34322
    URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
    Referència a l'article segons font original: International Journal Of Cancer. 152 (4): 572-599
    Referència de l'ítem segons les normes APA: Chan, Doris S. M.; Vieira, Rita; Abar, Leila; Aune, Dagfinn; Balducci, Katia; Cariolou, Margarita; Greenwood, Darren C.; Markozannes, Georgios; Nanu, (2023). Postdiagnosis body fatness, weight change and breast cancer prognosis: Global Cancer Update Program (CUP global) systematic literature review and meta-analysis. International Journal Of Cancer, 152(4), 572-599. DOI: 10.1002/ijc.34322
    DOI de l'article: 10.1002/ijc.34322
    Entitat: Universitat Rovira i Virgili
    Any de publicació de la revista: 2023
    Tipus de publicació: Journal Publications
  • Paraules clau:

    Cancer Research,Oncology
    Weight change
    To-hip ratio
    Systematic review
    Risk-factors
    Receiving adjuvant chemotherapy
    Pathological complete response
    Neoadjuvant chemotherapy
    Mass index bmi
    Life-style factors
    Evidence grading
    Endocrine therapy
    Early-stage
    Disease-free survival
    Breast cancer survival
    Body fatness
    Saúde coletiva
    Química
    Oncology
    Odontología
    Nutrição
    Medicina veterinaria
    Medicina iii
    Medicina ii
    Medicina i
    Interdisciplinar
    General medicine
    Educação física
    Ciências biológicas iii
    Ciências biológicas ii
    Ciências biológicas i
    Ciência de alimentos
    Cancer research
    Biotecnología
    Biodiversidade
  • Documents:

  • Cerca a google

    Search to google scholar